Evidence map›Paper›PMID 29464028›Full record

ArticleOncotarget2018

Consecutive epigenetically-active agent combinations act in

Hamid Sayar, Yan Liu, Rui Gao, Mohammad Abu Zaid, Larry D Cripe, Jill Weisenbach, Katie J Sargent, Mehdi Nassiri, Lang Li, Heiko Konig and 7 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Hamid SayarIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Yan LiuDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Rui GaoDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Mohammad Abu ZaidIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Larry D CripeIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Jill WeisenbachIndiana University Health Systems, Indianapolis, IN, USA.
Katie J SargentIndiana University Health Systems, Indianapolis, IN, USA.
Mehdi NassiriDepartment of Hematopathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Lang LiBiostatistics and Computational Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Heiko KonigIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Attaya SuvannasankhaIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Feng PanDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Rajasubramaniam ShanmugamIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Chirayu GoswamiBiostatistics and Computational Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Reuben KapurDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Mingjiang XuDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
H Scott BoswellIndiana University Melvin and Bren Simon Cancer Center, Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana University Health · USIndiana University School of MedicineIndiana University – Purdue University Indianapolis · US

Funding

Role of p21 activated kinase in LeukemogenesisR01CA173852 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPUR, REUBEN · 2014 to 2025
$3.4M
NCI NIH HHS R01 CA173852
6 · The paper itself

Abstract

Co-occurrence of

Indexed as

AMLbortezomibepigeneticssorafenibvorinostat

Identifiers

PMID29464028
PMCPMC5814168
OpenAlexW2781307366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.